lomustine has been researched along with Thrombocythemia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "14 patients with essential thrombocythemia (ET) and 1 patient with agnogenic myeloid metaplasia received (1-(2-chloroethyl)-cyclohexyl-nitrosourea (CCNU), 80 mg/m2, p." | 1.27 | 1-(2-Chloroethyl)-cyclohexyl-nitrosourea-induced remission in essential thrombocythemia. ( Grossi, A; Leoni, F; Rossi Ferrini, P, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leoni, F | 1 |
| Grossi, A | 1 |
| Rossi Ferrini, P | 1 |
1 other study available for lomustine and Thrombocythemia
| Article | Year |
|---|---|
1-(2-Chloroethyl)-cyclohexyl-nitrosourea-induced remission in essential thrombocythemia.
Topics: Adult; Age Factors; Aged; Alkylating Agents; Busulfan; Female; Humans; Leukemia, Myeloid, Acute; Lom | 1983 |